High-flying Fujifilm splashes $200M to beef up cell therapy capacity

High-flying Fujifilm splashes $200M to beef up cell therapy capacity

Source: 
Fierce Pharma
snippet: 

Fujifilm Corporation is spreading the wealth across two production units as the contract development and manufacturing organization (CDMO) juggernaut works through a cell therapy expansion.